|
The Journal of Nursing Research
Online Submission and Review System
|
|
I. Editorial Policy
The Editor of The Journal of Nursing Research (JNR) welcomes manuscripts on topics that are relevant and of interest to current nursing research in the realms of nursing practice, theory and philosophy. Manuscripts will be considered for publication on the understanding that they are original, meta-analysis research, or brief reports that have not been published previously and are not under consideration elsewhere. Authors must give a letter of consent stating exclusive submission to The Journal of Nursing Research.
All research conducted on human subjects must be approved by either an Institutional Review Board (IRB) or Community Review Board (CRB) and list approval number in the manuscript.
Duplicated or piecemeal publication is not allowed in accordance with the Publication Manual of the American Psychological Association (APA), 7th edition, 2020. If authors have previously published an article or have a manuscript that has been accepted for publication that is related or similar to the current submission, it is strongly recommended that the authors cite the article/manuscript in the current submission. All submitted manuscripts will be comparison checked against external databases. The editorial board reserves the right to reject submissions that do not pass this check.
AI Policy
Authors who use AI tools in the writing of a manuscript, production of images or graphical elements of the paper, or in the collection and analysis of data, must be transparent in disclosing in the Materials and Methods (or similar section) of the paper how the AI tool was used and which tool was used. Authors are fully responsible for the content of their manuscript, even those parts produced by an AI tool, and are thus liable for any breach of publication ethics.
GenAI
Authors are fully responsible for the content of their manuscript, even those parts produced by GenAI. Authors who have used GenAI in their research and the writing of manuscripts should provide an open, transparent, and detailed description of the use of GenAI (including the name and version of the GenAI tool, when it was used, how it was used, and the process of using it, and, if necessary, annotations for AI-assisted contents dealing with facts and opinions), and review of GenAI, following the body of the text, before the references, or in the method section (e.g., the authors have reviewed and edited the GenAI-produced content, and take full responsibility for the authenticity and accuracy of the content of this paper). It is recommended that authors submit and archive the GenAI-assisted sections (text, figures, programs, etc.) as supplementary material so that reviewers and editors can judge the accuracy, integrity, and originality of the paper.
Since GenAI cannot meet the requirements for authorship as they cannot take responsibility for the submitted work, GenAI -related products and developing teams cannot be listed as the author of a paper.
GenAI cannot be used to write an entire paper or a significant portion of a paper (e.g., method, result and analysis, etc.). All content that falls under the category of scientific contribution or intellectual labor should be finished by the author. If the main content of the paper is completed using GenAI, the editorial office will handle it as academic misconduct.
II. General Guidelines
Manuscript submissions will be accepted only via the website: http://www.editorialmanager.com/jnr/.
First-time users: Please click on the Register button from the menu above and enter all requested information. After completing and submitting your registration, you will receive an e-mail with your user name and password. Note: If you previously received a user ID and password from us or are a repeat user, please do not register again, and log in using your previously established account information. One registration is valid for multiple statuses (i.e., as author, reviewer, or editor). If you experience any problems, please contact:
The Journal of Nursing Research
Taiwan Nurses Association
4F, No. 281, Hsin-Yi Rd. Section 4
Taipei City, Taiwan 10681, ROC
Tel: + 886(2)27552291 ext. 25, 26
E-mail: [email protected]
http://www.twna.org.tw
Publication Ethics:
For the publications, we follow the guidelines of COPE- The Committee on Publication Ethics. (http://publicationethics.org/)
Format of Manuscript:
All manuscripts should be formatted double-spaced with one-inch margins for A4 paper. Preferred font is Times New Roman, 12 pt. All pages should be numbered consecutively, starting at the beginning of the article immediately after the abstract page.
For reporting guidelines of relevant research designs, please see the guidelines:
Observational cohort, case control and cross sectional studies
For observational cohort, case control and cross sectional studies, we suggest authors should follow the guideline STROBE (http://www.equator-network.org/reporting-guidelines/strobe/).
Quasi-experimental/non-randomized evaluations
For quasi-experimental/non-randomized evaluations studies, we suggest authors should follow the guideline TREND (http://www.cdc.gov/trendstatement/).
Randomized/quasi- randomized controlled trial
For randomized/quasi- randomized controlled trial studies, we suggest authors should follow the guide line such as CONSORT (http://www.equator-network.org/reporting-guidelines/consort/).
Systematic Review and Meta-Analyses
For Meta-Analyses, we suggest authors should follow the guide line such as PRISMA (http://www.equator-network.org/reporting-guidelines/prisma/).
Systematic Review of Observational Studies
III. Manuscript Structure
Title Page: Authors should provide manuscript titles and author information in title page. Author information should include: author name(s), use CAPITAL letters for author surname(s), credentials, institution(s) and country(ies), as well as correspondence name; address; telephone, cell phone and fax numbers; and e-mail address. List author Contribution under following titles: Study conception and design, Data collection, Data analysis and interpretation, Drafting of the article, Critical revision of the article. List title as "Topic/question: design/type of paper" and include population or care setting studied.
Abstract: Abstract should be around 300 words in length and not more than 400 words. Abstracts should be divided into paragraphs with the following headings: Background, Purpose, Methods, Results, and Conclusions / Implications for Practice. Abstract content should be substantively the same. Up to five key words should be provided.
Headings: The manuscript should be organized under headings such as Introduction, Methods, Results and Discussion.
Tables and Figures: Upload each table and figure to Editorial Manager as its own distinct file. Image files may be saved as TIFF, PDF, Word doc, PPT, or EPS file and should be created at a resolution adequate (or slightly more than adequate) to provide a clear print copy in the journal. Diagrams, drawings, graphs, and other line art must be in vector format or saved at a resolution >1200 dpi. Images created using MS Office should be converted to a high-resolution PDF (You may submit the original MS Office document(s) if you are unfamiliar with how to create PDF files). Photographs, radiographs and other halftone images must be saved at resolutions >300 dpi. Photographs and radiographs with text must be saved as postscript documents at resolutions >600 dpi. Remember to number figures (i.e., Figure 1, Figure 2, etc.) in the order in which they are discussed. Upload figures in proper sequence to the Editorial Manager website, and number figures consecutively in the Description box during upload. Please reference the following website to learn more about publication requirements related to digital artwork: http://links.lww.com/ES/A42. For qualitative research reports, do not prepare a table listing participants and their demographic characteristics.
Acknowledgments: Acknowledgments should be brief and limited to key contributors.
Conflicts of interest: Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest and Source of Funding:" For example:
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker's bureau for Organization X - the CME organizers for Company A. For the remaining authors none were declared.
A copy of the form is made available to the submitting author within the Editorial Manager submission process.
References and Style: Articles referred to in the manuscript should be fully cited, with at least half of references to articles dated within the last five years, and at least five references dated within the last three years preferred. References, photographs, tables and all other details of style must conform to the Publication Manual of the American Psychological Association (APA), 7th edition, 2020, which indicates that the "doi" should be included at the end of each reference, if applicable. No more than three references should be used to support a single idea. The number of references should not exceed 40 citations for original articles and 50 citations for meta-analysis articles. The APA format system uses names and years in the text, and literature sources are arranged in alphabetical order in the reference list by the surname of the first author. If a cited reference is in languages other than English, the addendum should be placed at the end of the reference. For example: "(Original work published in Chinese)".
IV. Types of Submissions
Original Research: Original research is a manuscript that presents novel nursing-relevant studies not yet addressed in previous reports. Original research should be no more than 4,500 words (double-spaced), excluding abstract, tables, figures, and reference list. Tables and figures together should be kept to fewer than 5. References should not exceed 40 citations for original articles and 50 citations for meta-analysis articles.
Brief Reports: Brief reports feature limited, critical studies; cutting edge ideas; well-done pilot studies; or studies with limited samples but important results. It should include a succinct abstract (up to 200 words); a body divided into the following sections: Introduction, Methods, Results, Discussion, Summary/ Implications for Practice; and no more than 15 references. Brief reports may be up to a maximum 1,500 words in length (a maximum of 2 tables and/or figures in total), not including the abstract.
V. Review
During the double-blind peer review process, the author may amend the manuscript no more than twice. Revised manuscripts should be resubmitted within two months. If a revised manuscript is not received by the editor of the JNR within the two-month period, the author will be considered as having abandoned his / her submission. After completion of peer review, the author may make no further substantive amendments to the manuscript. After a manuscript is accepted, it will be checked for proper spelling and grammar by JNR’s consultant. The author may apply for a certificate of publication from the JNR after the manuscript is accepted and approved for publication by the chief editor. After a manuscript is accepted for publication, no further amendments may be made by any author.
VI. Proofs
It is the author’s responsibility to check the accuracy of material appearing in proofs. Each proof should be returned within three days. Amendments made during proofreading should not substantively change the original content of the article.
PDF file will be supplied free to the correspondence author for each paper published. Accepted manuscripts become the property of The Journal of Nursing Research and may be reproduced in other publications in whole or in part only with the permission of the JNR. As declined manuscripts are not returned, authors should be sure to keep copies for their files.
VII. Open access
Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual unrestricted online access to their published article to readers globally, immediately upon publication. Authors may take advantage of the open access option at the point of submission. Please note that this choice has no influence on the peer review and acceptance process. These articles are subject to the journal's standard peer-review process and will be accepted or rejected based on their own merit.
The article processing charge (APC) is charged on acceptance of the article and should be paid within 30 days by the author, funding agency or institution. Payment must be processed for the article to be published open access. For a list of journals and pricing please visit our Wolters Kluwer Hybrid Open Access Journals page.
Authors retain copyright
Authors retain their copyright for all articles they opt to publish open access. Authors grant Wolters Kluwer an exclusive license to publish the article and the article is made available under the terms of a Creative Commons user license. Please visit our Open Access Publication Process page for more information.
Creative Commons license
Open access articles are freely available to read, download and share from the time of publication under the terms of the Creative Commons License Attribution-Non Commercial No Derivative (CC BY-NC-ND) license. This license does not permit reuse for any commercial purposes, nor does it cover the reuse or modification of individual elements of the work (such as figures, tables, etc.) in the creation of derivative works without specific permission.
Compliance with funder mandated open access policies
An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution (CC BY) license is able to meet that requirement through the available open access license for approved funders. Information about the approved funders can be found here.
Read and Publish Agreements
Wolters Kluwer currently has read-and-publish agreements with institutional consortia listed here.
Corresponding authors who are affiliated with the participating institution and who qualify as eligible authors* can publish their eligible articles open access in the eligible LWW journals at no direct cost to them. Please see your institution’s individual policy for guidance on eligible article types and license choice. To qualify for the APC waiver, the corresponding author must provide their participating institution’s name and institutional email address in the journal’s submission system. On acceptance, the corresponding author will be asked to place an open access order in the publisher’s payment portal where they will be able to request the APC be funded in accordance with this agreement. A $0.00 APC will then be applied.
*Eligible authors: Corresponding authors who are teaching and research staff employed by or otherwise accredited to one of the participating institutions as well as students enrolled or accredited to one of the institutions and who want to publish open access articles.
Compliance with National Institutes of Health Accessibility Requirements
The National Institutes of Health (NIH) requires authors to submit the “post-print” (the final manuscript, in Word format, after peer-review and acceptance for publication but prior to the publisher’s copyediting, design, formatting, and other services) of research the NIH funds to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the NIH to PubMed Central.
FAQ for open access
https://www.wolterskluwer.com/en/solutions/lippincott-journals/lippincott-open-access/faq
